FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a compound represented by formula (III), where R1-R3, L1, L2, ring A are defined in the claims, and a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing it, and the use of the compound.
EFFECT: compound can be used for the preparation of a medicinal product for the treatment of diseases associated with IRAK4.
20 cl, 2 dwg, 7 tbl, 60 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FGFR INHIBITOR AND ITS MEDICAL USE | 2018 |
|
RU2771311C2 |
| THIENODIAZEPINE DERIVATIVES AND THEIR USE | 2018 |
|
RU2795005C2 |
| S1P1 AGONIST AND ITS APPLICATION | 2017 |
|
RU2754845C2 |
| CONTAINING A SUBSTITUTE, WHICH IS BUTANE, IN THE HETEROCYCLIC RING A PYRIDONE DERIVATIVE FOR TREATING FIBROSIS AND INFLAMMATORY DISEASES | 2017 |
|
RU2738844C2 |
| MACROCYCLIC COMPOUND WITH FUNCTIONS OF WEE1 INHIBITOR AND ITS APPLICATION OPTIONS | 2018 |
|
RU2783243C2 |
| FUSED HETEROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USES THEREOF | 2014 |
|
RU2663999C2 |
| THIOPHENE COMPOUND, ITS PRODUCTION METHOD AND ITS PHARMACEUTICAL APPLICATION | 2017 |
|
RU2709473C1 |
| CDK4/6 INHIBITOR | 2017 |
|
RU2747311C2 |
| 2,3-DIHYDRO-1H-PYRROLISINE-7-FORMAMIDE DERIVATIVE AND ITS APPLICATIONS | 2019 |
|
RU2792726C2 |
| BORATE DERIVATIVE OF AZETIDINE | 2019 |
|
RU2802287C2 |
